HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of refractory psoriasis with fluocinonide gel.

Abstract
Twenty patients with refractory psoriasis that had responded poorly to previous therapy were treated with fluocinonide gel (0.05 percent), unoccluded, for six weeks. Patients were evaluated weekly. By the sixth week, all patients had improved, and seventeen (85 percent) showed "excellent" improvement. One patient discontinued the trial after four weeks because the lesions had completely cleared. No other patient discontinued using the medication for any reason. Patient complaints were minimal and consisted of stinging (three patients), itching (two patients), and drying (two patients). The study suggests that fluocinonide gel (0.05 percent) is a cosmetically acceptable alternative for the treatment of refractory psoriasis.
AuthorsC B Willoughby, W R Cook Jr
JournalCutis (Cutis) Vol. 20 Issue 1 Pg. 144-5 (Jul 1977) ISSN: 0011-4162 [Print] United States
PMID884957 (Publication Type: Journal Article)
Chemical References
  • Gels
  • Fluocinolone Acetonide
  • Fluocinonide
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Female
  • Fluocinolone Acetonide (analogs & derivatives)
  • Fluocinonide (administration & dosage, therapeutic use)
  • Gels
  • Humans
  • Male
  • Middle Aged
  • Psoriasis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: